Horien Biochemical Technology CoROCO:7814 +5.52%21 Interest Coverage is 596.86 as of Dec. 2025, which is 143% above its 10-year median of 245.12. GuruFocus rates ROCO:7814 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 377 Biotechnology companies, Horien Biochemical Technology Co ranks better than 58.36% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Horien Biochemical Technology Co's
Operating Income
for the
three
months ended in Dec. 2025 was NT$4.18 Mil. Horien Biochemical Technology Co's Interest Expense for the
three
months ended in Dec. 2025 was NT$-0.01 Mil.
Horien Biochemical Technology Co's interest coverage for the quarter that ended in Dec. 2025 was 596.86.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Horien Biochemical Technology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Horien Biochemical Technology Co's Interest Coverage or its related term are showing as below:
ROCO:7814'
s Interest Coverage Range Over the Past 10 Years
Min: 4.5 Med: 245.12 Max: 441.21
Current: 441.21
ROCO:7814's Interest Coverage is ranked better than 58.36% of 377
companies
in the Biotechnology industry
Industry Median: 106.07
vs ROCO:7814: 441.21
Horien Biochemical Technology Co (ROCO:7814) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Horien Biochemical Technology Co Interest Coverage Related Terms
Horien Biochemical Technology Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Horien Biochemical Technology Co Interest Coverage Chart
ROCO:7814 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Horien Biochemical Technology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Horien Biochemical Technology Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Horien Biochemical Technology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Horien Biochemical Technology Co's Interest Coverage falls into.
Horien Biochemical Technology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Horien Biochemical Technology Co (ROCO:7814) has a Interest Coverage of 596.86 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Horien Biochemical Technology Co and its competitors. This is 143% above median its historical median of 245.12. Over the past decade, Horien Biochemical Technology Co's Interest Coverage has ranged from 4.50 to 441.21. According to the industry distribution chart, Horien Biochemical Technology Co ranks #157 out of 377 companies in the Biotechnology industry, placing it in the top 41.6%.
Is Horien Biochemical Technology Co's Interest Coverage too high?
Horien Biochemical Technology Co's current Interest Coverage of 596.86 is 143% above median its 10-year median of 245.12. Over the past 10 years, this metric has ranged from a low of 4.50 to a high of 441.21. The Biotechnology industry median Interest Coverage is 106.07. Horien Biochemical Technology Co's value of 596.86 is 462.7% above this industry median. Based on the distribution chart, Horien Biochemical Technology Co ranks #157 out of 377 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Horien Biochemical Technology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Horien Biochemical Technology Co ranks #157 out of 377 companies for Interest Coverage. This puts Horien Biochemical Technology Co in the upper half of its industry. The industry median Interest Coverage is 106.07. Horien Biochemical Technology Co's value of 596.86 is 462.7% above this benchmark. Historically, Horien Biochemical Technology Co's own Interest Coverage has ranged from 4.50 to 441.21 over the past decade. While the company's 10-year median is 245.12 vs. the industry median of 106.07, Horien Biochemical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Horien Biochemical Technology Co's current Interest Coverage of 596.86 is 462.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Horien Biochemical Technology Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Horien Biochemical Technology Co's current Interest Coverage is 596.86, which is 143% above median its own 10-year median of 245.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current Interest Coverage of 596.86. The current Interest Coverage is 596.86, which is 143% above median its 10-year median of 245.12 and 462.7% above the Biotechnology industry median of 106.07. Horien Biochemical Technology Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current Interest Coverage is 596.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Horien Biochemical Technology Co Business Description
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
21GF Score
Get the complete analysis for ROCO:7814
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7814 has been successfully added to your 